Skip to main content

Day: February 16, 2022

ECGI Issues Shareholder Update Letter From the CEO

LOS ANGELES, Feb. 16, 2022 (GLOBE NEWSWIRE) — via InvestorWire – ECGI HOLDINGS INC. (OTC: ECGI) (“ECGI” or the “Company”), D/B/A Elite Cannabis Group Incorporated, a Nevada-based portfolio company pivoting into the legal cannabis and cannabinoid marketplace, is pleased to issue the following Letter to Shareholders from the Company’s CEO: Dear Valued Shareholder, I would like to begin today by expressing our sincere gratitude for your commitment, patience, and loyalty as shareholders of ECGI as we undertake a defining transition to drive shareholder value where we see a strong combination of strategic edge and outsized growth potential. We will fill in further details in coming communications, but we want shareholders to understand now that we have already taken important strides toward commercial stage operations in the cannabis...

Continue reading

BriaCell Appoints Renowned Oncologist, Giuseppe Del Priore, MD, MPH, as Chief Medical Officer

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 16, 2022 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces the appointment of Giuseppe Del Priore, MD, MPH, as the Company’s Chief Medical Officer (CMO), effective today. Dr. Del Priore will oversee the clinical and regulatory aspects of BriaCell’s current and upcoming clinical trials including the ongoing Phase I/IIa combination study of BriaCell’s lead candidate, Bria-IMT™, with Incyte’s checkpoint inhibitors, retifanlimab and epacadostat in advanced breast cancer. “We are thrilled to welcome Dr. Del Priore to our leadership team. Dr. Del Priore is an accomplished senior executive with extensive...

Continue reading

Aemetis India to Acquire Site for Biodiesel and Sustainable Aviation Fuel Feedstock Refining Facility

India biodiesel plant adds pre-treatment facility to convert crude tallow into refined tallow for biodiesel production and export of feedstock to California  CUPERTINO, CA, Feb. 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX), a renewable fuels company focused on negative carbon intensity products, announced today that the Universal Biofuels subsidiary of Aemetis in Kakinada, India has agreed to acquire a site to construct a tallow oil refining facility.  The refining facility is designed to supply feedstock to the existing Aemetis 50 million gallon per year biodiesel plant located on the East Coast of India and provide future feedstock supply to the Aemetis 90 million gallon sustainable aviation fuel (SAF) and renewable diesel (RD) plant being built in Riverbank, California.  “Our circular bioeconomy...

Continue reading

Great Lakes Reports Fourth Quarter and Full Year 2021 Results

Fourth quarter net income of $24.7 millionFourth quarter adjusted EBITDA of $48.2 millionFull year net income of $49.4 millionFull year adjusted EBITDA of $127.4 millionBacklog of $551.6 million at December 31, 2021 HOUSTON, Feb. 16, 2022 (GLOBE NEWSWIRE) — Great Lakes Dredge & Dock Corporation (“Great Lakes” or the “Company”) (Nasdaq:GLDD), the largest provider of dredging services in the United States, today reported financial results for the quarter and year ended December 31, 2021. Fourth Quarter 2021 HighlightsRevenue was $210.0 million for the fourth quarter 2021, a $37.9 million increase over the prior year fourth quarter. Gross margin percentage was 25.2% for the fourth quarter 2021 as compared to 19.4% in the prior year fourth quarter. Total operating income was $36.5 million, an increase of $19.2 million or 111.0%...

Continue reading

Fairfax Announces Acquisition of Additional Fairfax India Shares

TORONTO, Feb. 16, 2022 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) (“Fairfax”) announces that it has acquired, through its subsidiaries, an aggregate of 5,416,000 subordinate voting shares (the “Subordinate Voting Shares”) of Fairfax India Holdings Corporation (TSX: FIH.U) (“Fairfax India”), representing 4.93% of the issued and outstanding Subordinate Voting Shares of Fairfax India, from two existing shareholders at a price of US$12.00 (approximately C$15.29) per Subordinate Voting Share for an aggregate purchase price of approximately US$64.9 million (approximately C$82.8 million) (the “Share Purchase”). Prior to the Share Purchase, Fairfax beneficially owned, and/or exercised control or direction over, (i) 23,030,285 Subordinate Voting Shares, representing 20.97% of Fairfax India’s issued and outstanding...

Continue reading

AMC Networks Inc. Reports Full Year and Fourth Quarter 2021 Results

On track to achieve long-term target of 20 million to 25 million streaming subscribers by year-end 2025Ended 2021 with more than 9 million aggregate paid streaming subscribersFull year 2021 financial results exceeded financial outlook with record revenue NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) — AMC Networks Inc. (“AMC Networks” or the “Company”) (NASDAQ: AMCX) today reported financial results for the fourth quarter and full year ended December 31, 2021. Interim Chief Executive Officer Matt Blank said: “2021 was a strong, pivotal year for AMC Networks. We met or exceeded all of our guidance metrics, delivering the highest revenue in our company’s history and full-year U.S. advertising and subscription growth reinforcing the strength of our core business. We ended the year with more than nine million paid streaming...

Continue reading

Driven Brands Holdings Inc. Reports Fourth Quarter and Fiscal Year 2021 Results

Delivers Strong Same-Store Sales and Net Store Growth Reports Robust Operating Income and Earnings per Share Growth Provides Fiscal 2022 Guidance CHARLOTTE, N.C., Feb. 16, 2022 (GLOBE NEWSWIRE) — Driven Brands Holdings Inc. (NASDAQ: DRVN) (“Driven Brands” or “the Company”) today reported financial results for the fourth quarter and fiscal year ended December 25, 2021. For the fourth quarter, revenue was $391.9 million, an increase of 36% versus the prior year. System-wide sales were $1.2 billion, an increase of 26% versus the prior year, with 6% net store growth and an increase in consolidated same-store sales of 16.4%. The $(0.23) loss per diluted share in the fourth quarter was driven by a $56 million one-time transaction expense associated with the acquisition of Auto Glass Now (“AGN”), which closed on December 30, 2021. Adjusted...

Continue reading

Altra Reports Fourth Quarter 2021 Results

Announced Acquisition of Nook Industries and Agreement to Divest JVS Strong Demand Continues Across Nearly All End Markets Resulting in Record Sales for the Year November 2021 $1.4 Billion Refinancing Supports Further Inorganic Growth Provides 2022 Guidance BRAINTREE, Mass., Feb. 16, 2022 (GLOBE NEWSWIRE) — Altra Industrial Motion Corp. (Nasdaq: AIMC) (“Altra” or the “Company”), a leading global manufacturer and supplier of motion control, power transmission and automation products, today announced unaudited financial results for the fourth quarter ended December 31, 2021. Q4 2021 Financial Highlights  Q4 2021 Q4 2020 YOY ChangeNet sales $469.8M $453.2M 3.7%  • Q4 2021 Organic Sales Growth was 4.1% for the combined business compared with the fourth quarter of 2020.*• Q4 2021 Power Transmission Technologies (PTT) segment...

Continue reading

Cellebrite Announces Fourth Quarter and Full Year 2021 Results

2021 revenue of $246 million, up 26% year-over-year 2021 ARR $187 million, up 37% year-over-year 2021 GAAP net income of $71.4 million; Adjusted EBITDA of $47.9 million, 19.5% Adjusted EBITDA margin Provides 2022 outlook for 34-42% ARR growth and 16-22% revenue growth PETAH TIKVA, Israel, Feb. 16, 2022 (GLOBE NEWSWIRE) — Cellebrite (Nasdaq: CLBT), a global leader in Digital Intelligence (“DI”) solutions for the public and private sectors, today announced financial results for the three months and full year ended December 31, 2021. “We delivered a record revenue quarter, closing a strong year of record ARR, revenue, and operating profitability, while continuing to successfully execute on our strategy to modernize the entire investigative process for our customers,” said Yossi Carmil, Cellebrite’s CEO. “Our markets are healthy, our...

Continue reading

Otonomy Announces OTO-413 Presentations at American Auditory Society Annual Meeting

SAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) —  Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced two upcoming presentations on the OTO-413 hearing loss program at the 49th Annual Scientific and Technology Meeting of the American Auditory Society (AAS) to be held February 24-26, 2022 in Scottsdale, Arizona. These include a podium presentation of previously disclosed results from the OTO-413 Phase 1/2 clinical trial and a general review of the OTO-413 program as an invited presentation in a special session on hearing therapeutics. Details of these presentations are as follows: Podium Presentation Title: Neurotrophin OTO-413 for hearing loss: Phase 1/2 clinical studyDate and Time: February 24, 2022 from 4:00-4:20 p.m. MSTPresenter: David...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.